LHC: LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Publication of circular and details regarding trading update
Publication of circular and details regarding trading update
Life Healthcare Group Holdings Limited
Incorporated in the Republic of South Africa
Registration Number: 2003/002733/06
ISIN: ZAE000145892
Share Code: LHC
("Life Healthcare" or "the Company")
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, AUSTRALIA
AND JAPAN. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED
STATES OR ANY OTHER JURISDICTION.
PUBLICATION OF CIRCULAR AND DETAILS REGARDING TRADING UPDATE
Further to the rights offer finalisation announcement ("Finalisation Announcement") released on SENS on 23 March 2017 and
published in the press on 24 March 2017, Life Healthcare confirms that the rights offer circular will be published on Life Healthcare´s
website (www.lifehealthcare.co.za), today 28 March 2017 and will be posted to qualifying certificated shareholders on 30
March 2017. Where applicable, the rights offer circular will be posted to qualifying dematerialised shareholders on 4 April 2017.
With reference to the current trading commentary set out in the Finalisation Announcement and the rights offer circular, Life
Healthcare shareholders are advised that the Company expects to have greater clarity regarding the matters set out in the trading
update and intends to release an announcement in relation thereto on or about 4 April 2017 including a trading statement if
required.
Illovo
28 March 2017
Sponsor
RAND MERCHANT BANK (a division of FirstRand Bank Limited)
Important Notice
The information contained herein is not for release, publication or distribution, directly or indirectly, in or into Canada, Australia or
Japan or any other jurisdiction in which the distribution or release would be unlawful. These materials are not and do not contain
an offer of securities for sale or a solicitation of an offer to purchase or subscribe for securities in any jurisdiction, including the
United States, Australia, Canada or Japan or any other state or jurisdiction in which such release, publication or distribution would
be unlawful. The securities to which these materials relate (the "Securities") have not been, and will not be, registered under the
U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States unless
registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, registration under the
Securities Act. There will be no public offer of the Securities in the United States. Subject to certain exceptions, the Securities
may not be offered or sold in the United States, Australia, Canada or Japan or to, or for the account or benefit of, any national,
resident or citizen of such countries.
These materials are only being distributed to and are only directed at: (i) persons who are outside the United Kingdom; or (ii) to
investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order
2005 (the "Order"); or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article
49(2) of the Order; or (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of
section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise
lawfully be communicated; or (v) persons to whom it may otherwise lawfully be communicated (all such persons together being
referred to as "relevant persons"). The Securities are only available to, and any invitation, offer or agreement to subscribe,
purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant
person should not act or rely on this announcement or any of its contents.
In any member state of the European Economic Area (other than the United Kingdom) that has implemented Directive 2003/71/EC
(and amendments thereto, including Directive 2010/73/EU to the extent implemented in the relevant Member State, together with
any applicable implementing measures in any Member State, the "Prospectus Directive") this announcement is only addressed
to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.
These materials do not constitute or form a part of any offer or solicitation or advertisement to purchase and/or subscribe for
Securities in South Africa, including an offer to the public for the sale of, or subscription for, or the solicitation or advertisement of
an offer to buy and/or subscribe for, shares as defined in the South African Companies Act, No. 71 of 2008 (as amended) or
otherwise (the "Act") and will not be distributed to any person in South Africa in any manner that could be construed as an offer
to the public in terms of the Act. These materials do not constitute a prospectus registered and/or issued in terms of the Act.
Nothing in this announcement should be viewed, or construed, as "advice", as that term is used in the South African Financial
Markets Act, No. 19 of 2012, as amended, and/or Financial Advisory and Intermediary Services Act, No. 37 of 2002, as amended.
The contents of this announcement have not been verified by the banks engaged to underwrite the offering (the "Banks"). The
Banks are each acting exclusively for Life Healthcare and for no-one else in connection with any transaction mentioned in these
materials and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to any such
transaction and will not be responsible to any other person for providing the protections afforded to their respective clients, or for
advising any such person on the contents of these materials or in connection with any transaction referred to in this
announcement.
No reliance may be placed for any purposes whatsoever on the information contained in this announcement or on its accuracy
or completeness. No representation or warranty, expressed or implied, is given by or on behalf of Life Healthcare, the Banks or
their respective affiliates, directors, officers or employees, advisors or any other person as to the accuracy or completeness of
the information or opinions contained in this announcement, and no liability whatsoever is accepted for any such information or
opinions or any use which may be made of them.
Persons receiving this announcement should make all trading and investment decisions in reliance on their own judgement and
not in reliance on the Banks or this document. None of the Banks is providing any such persons with advice on the suitability of
the matters set out in this announcement or otherwise providing them with any investment advice or personal recommendations.
Any presentations, research or other information communicated or otherwise made available in this document is incidental to the
provision of services by the Banks to Life Healthcare and is not based on individual circumstances.
All investment is subject to risk. The value of the securities offered may go down as well as up. Past performance is no guarantee
of future returns. Potential investors are advised to seek expert financial advice before making any investment decision.
Date: 28/03/2017 04:17:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.